Subsequently, we showed that GLP-1 induces satiety equally well in people with obesity [10]
Extracorporeal treatment to enhance VPA elimination, preferentially using intermittent hemodialysis, is only recommended in the most severe cases [7, 8]
Its a popular choice because the muscle is substantial, and the area typically has fewer nerve endings, which can mean less discomfort during the injection
In other words, manipulating a prescription outside of the intended use or extending it may cause safety concerns and consequences unaccounted for in research studies. If its unsafe to use any leftover medication in the pen after four weeks of injections, GLP-1 users may wonder whats the safest way to dispose of it
Aging Clin Exp Res 36(1):185 Coskun T, Wu Q, Schloot NC, Haupt A, Milicevic Z, Khouli C et al (2025) Effects of Retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
R.PowellF